Introduction
============

According to the World Health Organization, approximately 200,000-400,000 new cases of visceral leishmaniasis (VL) occur every year in the world, 90% of which are noted in Southeast Asia, Latin America and East Africa ([@b1-etm-0-0-8487]). Based on the continuous emergence of new VL cases, the Indian subcontinent, Nepal, and Bangladesh were affected by VL and had to postpone the plan to eliminate VL from 2015 until 2020([@b2-etm-0-0-8487]). Western cities of China such as Xinjiang, Gansu, Sichuan and other provinces as well as autonomous regions were endemic areas of VL ([@b3-etm-0-0-8487]). The abundant epidemiological data and the high incidence rate provided the clinicians with sufficient knowledge regarding the incidence of the disease in endemic areas, leading to a high detection rate. However, it is difficult to diagnose imported cases in non-epidemic areas due to factors, such as the population mobility and low attention to the disease ([@b4-etm-0-0-8487]). Moreover, clinical manifestations and disease symptoms or signs may produce additional confusion. The absence of the medical history of patients resident in epidemic areas may lead to misdiagnosis of the disease ([@b5-etm-0-0-8487]). Based on research statistics, the misdiagnosis rate of clinical VL can reach 23.4% ([@b6-etm-0-0-8487]). VL is characterized by intermittent fever, hepatosplenomegaly, pancytopenia and polyclonal hyperimmune globulinemia. These symptoms are easily confused with AIDS, aplastic anemia, and plasma cell systemic diseases ([@b7-etm-0-0-8487],[@b8-etm-0-0-8487]). The diagnosis of VL is based on the detection of *Leishmania* amastigotes in the human body ([@b3-etm-0-0-8487],[@b9-etm-0-0-8487]). This should be differentiated from *Penicillium marneffei*, Histoplasma, and *Plasmodium* ([@b10-etm-0-0-8487]). The prognosis of VL is very poor and it mainly depends on early diagnosis and targeted therapy. Sodium antimony gluconate treatment was recommended for the treatment of *Leishmaniasis* in China. However, certain studies have applied sodium antimony gluconate and amphotericin B in the treatment of relapse and refractory cases due to the development of clinical resistance ([@b11-etm-0-0-8487],[@b12-etm-0-0-8487]). In order to improve the diagnostic rate and curative effect of VL, the present study combined the latest domestic and overseas research progress with the clinical data derived from VL-suspected cases, including laboratory diagnosis, diagnostic methods, relapse and other refractory cases.

Case report
===========

In November 2010, a 25-year-old man from the Jiangxi Province of China was admitted to a local hospital due to left oblique hernia. He had hepatosplenomegaly during physical examination and his abdominal magnetic resonance imaging scan indicated portal vein dilatation (14 mm). The blood examinations revealed severe pancytopenia and chronic HBV infection. Significant plasma cell infiltration (12.5%) was noted following bone marrow aspiration. Therefore, multiple myeloma was suspected. On the 29th of December 2010, the patient was transferred to our clinic. The patient worked as an excavator driver in a gold mine in the Sichuan Province of China in the past two years. A year ago, he began to suffer from low fever and night sweats, accompanied with fatigue. Administration of a Chinese herbal medicine resulted in the elimination of the fever, whereas fatigue and intermittent nighttime sweat continued until his hospitalization. He did not receive any further treatment.

The patient exhibited no past medical history, and did not receive any supplements, illicit drugs, raw meat or unpasteurized milk. His family and personal history did not include associated diseases or disorders. However, it was reported that he had frequent sexual intercourse with different female partners. In addition, he was indirectly exposed to farm animals and pets without having close contact with them, whereas his family was not engaged in agricultural works. He denied tick or flea infections, blood transfusion and the presence of osteodynia or arthralgia. He never smoked and was not an alcoholic. On physical examination the patient did not exhibit fever and appeared pale and sweaty. The cardiorespiratory examination was unremarkable. A markedly tender and enlarged liver and spleen were noted that were located 5 and 11 cm below the costal margins, respectively. No rashes, dryness of eyes, mouth ulcers, or mucocutaneous bleeding were noted. Several palpable lymph nodes with an approximate diameter of 1 cm were noted in the supraclavicular fossa and groin. No skin lesion or sedimentation was noted. Periorbital or peripheral extremity edema was not present. The patient exhibited a left oblique hernia, which appeared two months ago.

The laboratory values are presented in [Table I](#tI-etm-0-0-8487){ref-type="table"}. Urine and stool examinations were normal. The erythrocyte sedimentation rate was 120 mm/h and the C-reactive protein was 12 mg/dl. Severe pancytopenia was present with neutropenia, mild thrombopenia and normocytic normochromic anemia. In addition, the patient experienced hypoalbulinemia and hyperglobulinemia and immunoelectrophoresis demonstrated an elevation of IgG and IgA ([Table I](#tI-etm-0-0-8487){ref-type="table"}). X-ray imaging indicated no evidence of bone damage. Subsequently, a new bone marrow aspiration and biopsy were performed to confirm the previous diagnosis on the 27th of December 2010. Bone marrow smears were rich in mononuclear cells. The percentage of erythrocyte series was 44% and the cells were uncoiled, with erythroblastic anisocytosis. The percentage of granulocyte series was 36.5% and it exhibited a light deviation to the left side. The percentage of lymphoplasmocyte series was 17.5%, including heteromorphic plasmocytes (uni- and binuclear), lympho-plasmocytes and lymphocytes. The percentage of the megakaryocyte series was estimated to 2%, with frequent thrombocytogenic megakaryocytes. Bone marrow biopsy indicated hypercellular bone marrow with infiltration of plasmocytes. At this stage, reactive plasmacytosis was highly suspected, although it was previously shown that certain viruses, such as hepatitis viruses, rarely cause this degree of hepatosplenomegaly. The potential interactions caused by inflammatory conditions, chronic infections, autoimmune diseases, hypersensitivity states and malignancy, were also taken into account.

Parasite infectious etiology was suspected from the epidemic of *schistosomiasis* in the patient\'s hometown at the Jiangxi Province. However, serological analyses did not reveal bacterial infections with the exception of a past infection of respiratory syncytial viruses and HBV ([Table II](#tII-etm-0-0-8487){ref-type="table"}). The presence of antibodies against viruses, bacteria or parasites was not detected and multiple cultures of blood, urine and stool revealed negative results. The presence of anti-nuclear antibodies was negative and the concentration levels of the complement proteins were within the normal range. Positron Emission Tomography/Computed Tomography (PET/CT) revealed no evidence of malignancy, although substantial hepatosplenomegaly was evident in combination with dilatation of the portal vein (14 mm) and small levels of ascites ([Fig. 1](#f1-etm-0-0-8487){ref-type="fig"}). Magnetic resonance portal venography (MRPVG) indicated dilatation of the spleen and the portal veins at a diameter of 1.6 and 1.5 cm, respectively, whereas no evidence of canalization of collateral circulation, stenosis or arteriovenous shunt of major vessels was noted. On the 10th of January 2011, bone marrow biopsy was performed again and the smear sample indicated the presence of extracellular ([Fig. 2](#f2-etm-0-0-8487){ref-type="fig"}) and intra-macrophage amastigotes ([Fig. 3](#f3-etm-0-0-8487){ref-type="fig"}), which lacked an exteriorized flagellum. Detection method of worms in bone marrow smear: Bone marrow slides containing particles were prepared according to ICSH guidelines, using a Wright-Giemsa Stain kit (Baso Diagnostic Inc.), and then examined under a microscope. The marrow cellularity was observed under low power magnification (x100) to find suspicious cell or extracellular protozoa, and then confirm under the oil mirror (x1,000) whether it is a Leishmania (Microscope model: Olympus CX23). The cells were morphologically assessed and the data revealed that they were possibly amastigotes of *Leishmania* (*Leishmania*) *donovani*. To confirm this diagnosis, blood samples were sent to the Institute of parasitic disease, at the Chinese Center for Disease Control and Prevention. The plasma *Leishmania-donovani* antibody was positive. Therefore, the present case was diagnosed as VL. The patient was immediately treated on the 12th of January with anti-leishmanial therapy intramuscularly, which consisted of 600 mg sodium stibogluconate. The patient tolerated the 10-day-treatment and exhibited only a minimal arthralgia. Moreover, leukopenia and monocytosis disappeared at the beginning of February. Bone marrow biopsy was performed on the 21st of March in 2011 and was negative for amastigotes. The patient was discharged on the 25th of March 2011 with no medication. No relapse has been reported to date.

Discussion
==========

VL, which is caused by the *Leishmania* *donovani* group of protozoa, is highly prevalent in mainland China. However, since the end of the 1950s, a national campaign was conducted, which resulted in the significant reduction of the disease epidemic ([@b13-etm-0-0-8487]). Sporadic cases have occurred in the newly reclaimed desert areas, such as the Xinjiang, Gansu, Sichuan, Shaanxi and Shanxi provinces ([@b14-etm-0-0-8487]). Sporadic cases have also occurred in Inner Mongolia and the Xinjiang Uygur Autonomous Region ([@b14-etm-0-0-8487]). However, the disease was still prevalent or sporadic in some cities in western China after the 1990s ([@b4-etm-0-0-8487]). In the present case report, a patient was included who lived during the recent two years in the Sichuan province. This region is located in the southwest of China. The north area of the Sichuan province is known as an endemic area of VL. It was speculated that he was infected there.

The immune response during the chronic infection of *Leishmania* is complicated. In the present case, the polyclonal hyperimmunoglobulinemia, which led to the diagnosis of reactive plasmocytosis, reflected the overstimulated state of humoral immunity. However, the immunoglobins stimulated by the parasite antigen were not primarily important for the protection of the patient and were involved in the pathogenesis of tissue lesions ([@b15-etm-0-0-8487]). The assessment of cytoimmunity was assessed by lymph node biopsy, which demonstrated a diffuse reactive proliferation of T cells. However, the peripheral blood examination demonstrated that the patient experienced severe leukopenia and low levels of CD~4~, CD~8~ T cells and NK cells. This maybe the result of a chronic stimulation of the *Leishmania* antigen and of a variety of general suppressive mechanisms, including soluble factors ([@b16-etm-0-0-8487]), sensitivity of different cell types ([@b17-etm-0-0-8487]) and interactions of cytokines ([@b18-etm-0-0-8487]).

Human infections can be asymptomatic or can manifest as oligosymptomatic and progressive diseases. The diagnosis of VL in an asymptomatic patient is challenging. The symptoms of VL consist of malaise, weakness, weight loss and high-grade intermittent fever. The liver and spleen progressively increase in size. Hyperpigmentation is also common (black fever). Peripheral blood exhibits progressive leukopenia with relative and absolute monopenia, normocytic anemia and thrombocytopenia that are encountered in the initial and late stages, respectively ([@b19-etm-0-0-8487]). These symptoms and the incidence of AIDS and aplastic anemia are similar with the exception that the latter two diseases are generally not associated with progressive hepatosplenomegaly. In the present case report, the patient did not exhibit fever during his admission in our clinic and following the administration of Chinese herbal drugs. It remains unclear whether the patient\'s left oblique hernia was caused by a prolonged infection with *Leishmania* that enlarged the liver and spleen and increased abdominal pressure, or whether other factors were present that caused abnormal changes in the peritoneum. The bone marrow biopsy presented as reactive plasmacytosis and this might have led the physician to misdiagnosis. To avoid misdiagnosis of leishmaniasis with malignant B cell diseases, it is important to be aware of the differences between reactive plasmacytosis and multiple myeloma that are both present in the clinical features and pathological characteristics of these two conditions. The immunohistochemical study revealed a polytypic nature of the plasma cells. Moreover, electrophoresis was mainly indicative of a broad-based polyclonal hyperimmunoglobulinemia in reactive plasmacytosis.

The diagnosis of VL is mainly focused on the detection of *Leishmania* *malformans* in human tissues. The sensitivity of detection depends on the type of tissue. Although, the spleen aspirate is higher than 90%, the risk retrieving the sample from the spleen is considerably high. The positive rate of detection is estimated from 50 to 80% in the lymph node and in blood samples ([@b20-etm-0-0-8487]). *Leishmania no-flagellate* should be readily distinguished from *Penicillium* *marneffei*, histoplasma and Plasmodium. *Penicillium marneffei* is a fungus and its cells are sausage-shaped, with a transverse septum. In the present study, the cell wall was detected by periodic acid-Schiff staining and the cytoplasm was not colored. The histoplasma was a fungus, which exhibited a round or oval shape. It resembled a capsule and the periodic acid-Schiff stained cell wall was red and clear. The cytoplasm was not stained. The Plasmodium was stained red-nuclear following Wright\'s staining and the cytoplasm was azure to dark blue. The malaria pigment has been shown to be brownish yellow and brown or dark brown ([@b4-etm-0-0-8487]).

The detection of protozoa may yield certain false negative results and it is complemented by clinical detection with serological antibody detection technology (rk39 kit). Although this method is fast and sensitive, it is used in patients with immunodeficiency with very low detection rate. Moreover, this method lacks the ability to distinguish between active or previous infections ([@b21-etm-0-0-8487]). Recent advances in molecular biology techniques and second-generation sequencing can improve the current method and increase the diagnostic value and dynamic monitoring of VL diseases ([@b1-etm-0-0-8487]).

Currently, the first-line drug used for VL in China is mainly sodium antimony gluconate. However, in other countries this treatment is combined with amphotericin B ([@b3-etm-0-0-8487]).
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![PET/CT indicated a significant enlarged liver and spleen (Hepatosplenomegaly with red coils in the figure). PET, Positron emission tomography; CT, computerized tomography.](etm-19-04-2697-g00){#f1-etm-0-0-8487}

![Bone marrow aspirate indicating extra-cellular promastigote *Leishmania* bodies, inside the red circle (Wright-Giemsa stain; original magnification, x1,000).](etm-19-04-2697-g01){#f2-etm-0-0-8487}

![(A) and (B) Intracellular amastigotes (arrow pointing to the cell, Wright-Giemsa stain; original magnification, x1,000).](etm-19-04-2697-g02){#f3-etm-0-0-8487}

###### 

Laboratory values.

  Examination                            Value
  -------------------------------------- -------
  Urinalysis                             
       Glucose                           (-)
       Protein                           (-)
       Erythrocytes (µl)                 2
       Leucocytes (µl)                   3
       Cast (/HP)                        0
       Bacteria (/HP)                    0
  Stool                                  
       Occult blood                      (-)
       Ova                               (-)
  Hematological values                   
       ESR (mm/h)                        120
       Leucocyte (/µl)                   1,300
  Differential count (/µl)               
       Neutrophils (/µl)                 600
       Lymphocytes (/µl)                 500
       Monocytes (/µl)                   200
       Eosinophils (/µl)                 0
       Erythrocyte (10^4^/µl)            272
       Hemoglobin (g/ml)                 7.4
       Hematocrit (%)                    23.4
       Platelets (10^4^/µl)              8.5
       Anti-platelet IgG (ng/10^7^ PA)   352.1
       Anti-platelet IgM                 50.3
       Anti-platelet IgA                 1.8
       CRP (mg/l)                        12
  Blood chemical values                  
       Total protein (g/dl)              84.3
       Albumin (g/dl)                    22.7
       Globulin (g/dl)                   61.6
       IgG (g/l)                         39.20
       IgA (g/l)                         0.52
       IgM (g/l)                         1.97
       κ (g/l)                           10.4
       λ (g/l)                           4.47
       BUN (mmol/l)                      4.2
       Creatinine (mmol/l)               51.6
       Na (mmol/l)                       130.3
       K (mmol/l)                        4.0
       Cl (mmol/l)                       107.1
       β2-MG (ng/ml)                     6,246
       Urinoβ2-MG (µg/l)                 248
       CD~3~%                            23.9
       CD~4~%                            6.7
       CD~8~%                            6.9
       CD~16+56~ (NK,%)                  1.0
       LDH (U/l)                         187
       AST (U/l)                         11
       ALT (U/l)                         16
       γ-GT (U/l)                        32
       Alkaline phosphatase (U/l)        99
       Total bilirubin (mg/dl)           20.1

(-), Negative; ESR, erythrocytes sedimentation rate; CRP, C-reaction protein; BUN, blood urea nitrogen; LDH, lactate dehydrogenase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GT, γ-glutamyl transpeptidase.

###### 

Serological studies.

  Tests                       Result
  --------------------------- --------
  HBV-sAg, cAb, eAb           (+)
  Anti-HCV Ab                 (-)
  Anti-CMV IgM, IgG           (-)
  Anti-EBV IgM, IgG           (-)
  Anti-RSV IgG                (+)
  Anti-HIV Ab                 (-)
  Anti-HSV-1 IgG              (-)
  Anti-toxoplasma IgG         (-)
  Brucellosis                 (-)
  Anti-mycoplasma Ab          (-)
  Candida Ag                  (-)
  Vidal\'s reaction           (-)
  Rheumatoid factor (IU/ml)   15.6
  Antistreptolysin O          (-)
  Anti-dsDNA Ab               (+)
  Candida Ag                  (-)
  Anti-nuclear Ab             (-)
  CH50 (U/ml)                 45.18
  C3 (g/l)                    0.86
  C4 (g/l)                    0.09

HBV, hepatitis B virus; Ag, antigen; Ab, antibody; HCV, hepatitis C virus; CMV, cytomegalovirus; EBV, Epstein-Barr virus; RSV, respiratory syncytial viruses; HIV, human immunodeficiency virus; HSV, herpes simplex virus; Ig, immunoglobulin; CH50, complement hemolytic activity.
